143 related articles for article (PubMed ID: 9872352)
1. Benfotiamine in treatment of alcoholic polyneuropathy: an 8-week randomized controlled study (BAP I Study).
Woelk H; Lehrl S; Bitsch R; Köpcke W
Alcohol Alcohol; 1998; 33(6):631-8. PubMed ID: 9872352
[TBL] [Abstract][Full Text] [Related]
2. [Medicamentous therapy of alcoholic polyneuropathy. Randomized double-blind study comparing 2 vitamin B preparations and a nucleotide preparation].
Kretschmar C; Kaumeier S; Haase W
Fortschr Med; 1996 Nov; 114(32):439-43. PubMed ID: 9064269
[TBL] [Abstract][Full Text] [Related]
3. A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy.
Stracke H; Lindemann A; Federlin K
Exp Clin Endocrinol Diabetes; 1996; 104(4):311-6. PubMed ID: 8886748
[TBL] [Abstract][Full Text] [Related]
4. Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).
Haupt E; Ledermann H; Köpcke W
Int J Clin Pharmacol Ther; 2005 Feb; 43(2):71-7. PubMed ID: 15726875
[TBL] [Abstract][Full Text] [Related]
5. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study.
Stracke H; Gaus W; Achenbach U; Federlin K; Bretzel RG
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):600-5. PubMed ID: 18473286
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence.
Manzardo AM; He J; Poje A; Penick EC; Campbell J; Butler MG
Drug Alcohol Depend; 2013 Dec; 133(2):562-70. PubMed ID: 23992649
[TBL] [Abstract][Full Text] [Related]
7. Treatment of alcoholic polyneuropathy with vitamin B complex: a randomised controlled trial.
Peters TJ; Kotowicz J; Nyka W; Kozubski W; Kuznetsov V; Vanderbist F; de Niet S; Marcereuil D; Coffiner M
Alcohol Alcohol; 2006; 41(6):636-42. PubMed ID: 16926172
[TBL] [Abstract][Full Text] [Related]
8. [Diabetic polyneuropathy treatment by milgamma-100 preparation].
Sadekov RA; Danilov AB; Veĭn AM
Zh Nevrol Psikhiatr Im S S Korsakova; 1998; 98(9):30-2. PubMed ID: 9791922
[TBL] [Abstract][Full Text] [Related]
9. [The effect of benfothiamine in the therapy of diabetic polyneuropathy].
Nikolić A; Kacar A; Lavrnić D; Basta I; Apostolski S
Srp Arh Celok Lek; 2009; 137(11-12):594-600. PubMed ID: 20069914
[TBL] [Abstract][Full Text] [Related]
10. Change in psychiatric symptomatology after benfotiamine treatment in males is related to lifetime alcoholism severity.
Manzardo AM; Pendleton T; Poje A; Penick EC; Butler MG
Drug Alcohol Depend; 2015 Jul; 152():257-63. PubMed ID: 25908323
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of different benfotiamine dosage regimens in the treatment of painful diabetic neuropathy.
Winkler G; Pál B; Nagybéganyi E; Ory I; Porochnavec M; Kempler P
Arzneimittelforschung; 1999 Mar; 49(3):220-4. PubMed ID: 10219465
[TBL] [Abstract][Full Text] [Related]
12. Variability of skin autofluorescence measurement over 6 and 12 weeks and the influence of benfotiamine treatment.
Stirban A; Pop A; Fischer A; Heckermann S; Tschoepe D
Diabetes Technol Ther; 2013 Sep; 15(9):733-7. PubMed ID: 23964994
[TBL] [Abstract][Full Text] [Related]
13. Vitamin B and its derivatives for diabetic kidney disease.
Raval AD; Thakker D; Rangoonwala AN; Gor D; Walia R
Cochrane Database Syst Rev; 2015 Jan; 1():CD009403. PubMed ID: 25579852
[TBL] [Abstract][Full Text] [Related]
14. Pain Bloc-R Alleviates Unresolved, Non-Pathological Aches and Discomfort in Healthy Adults-A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
Evans M; Sulley AM; Crowley DC; Langston J; Guthrie N
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32575480
[TBL] [Abstract][Full Text] [Related]
15. Synergistic antiallodynic interaction between gabapentin or carbamazepine and either benfotiamine or cyanocobalamin in neuropathic rats.
Mixcoatl-Zecuatl T; Quinonez-Bastidas GN; Caram-Salas NL; Ambriz-Tututi M; Araiza-Saldana CI; Rocha-Gonzalez HI; Medina-Santillan R; Reyes-Garcia G; Granados-Soto V
Methods Find Exp Clin Pharmacol; 2008; 30(6):431-41. PubMed ID: 18850044
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, crossover, placebo-controlled trial of 6 weeks benfotiamine treatment on postprandial vascular function and variables of autonomic nerve function in Type 2 diabetes.
Stirban A; Pop A; Tschoepe D
Diabet Med; 2013 Oct; 30(10):1204-8. PubMed ID: 23701274
[TBL] [Abstract][Full Text] [Related]
17. Comment on Wang et al.: Thiamine, pyridoxine, cyanocobalamin and their combination inhibit thermal, but not mechanical hyperalgesia in rats with primary sensory neuron injury (Pain 2005;114:266-77).
Shir Y
Pain; 2005 Jul; 116(1-2):168; author reply 169. PubMed ID: 15927396
[No Abstract] [Full Text] [Related]
18. [Oral benfotiamine therapy. Thus you protect the nerves of diabetic patients].
MMW Fortschr Med; 2004 Jan; 146(5):52-3. PubMed ID: 15035429
[No Abstract] [Full Text] [Related]
19. [Therapy of neuropathies with a vitamin B combination. Symptomatic treatment of painful diseases of the peripheral nervous system with a combination preparation of thiamine, pyridoxine and cyanocobalamin].
Eckert M; Schejbal P
Fortschr Med; 1992 Oct; 110(29):544-8. PubMed ID: 1330858
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of advanced glycation end-products inhibitor in osteoarthritis: a randomized, double-blind, placebo-controlled study.
Garg S; Syngle A; Vohra K
Clin J Pain; 2013 Aug; 29(8):717-24. PubMed ID: 23354008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
